Multiple sclerosis and its impact on dental care.
Journal
British dental journal
ISSN: 1476-5373
Titre abrégé: Br Dent J
Pays: England
ID NLM: 7513219
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
30
11
2020
accepted:
24
01
2021
entrez:
11
9
2021
pubmed:
12
9
2021
medline:
21
10
2021
Statut:
ppublish
Résumé
Multiple sclerosis affects approximately 130,000 people in the UK. Due to the wide variation in the symptoms associated with this condition and their variable severity, the provision of dental care for affected patients must be determined by an individual's specific needs. This will often vary significantly over time. This paper reviews the aetiology, presentation and current management of multiple sclerosis, and explores the impact of these on oral health and the provision of dental care.
Identifiants
pubmed: 34508197
doi: 10.1038/s41415-021-3333-0
pii: 10.1038/s41415-021-3333-0
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
281-286Informations de copyright
© 2021. The Author(s), under exclusive licence to British Dental Association.
Références
National Institute for Health and Care Excellence. NICE Clinical Knowledge Summaries: Multiple sclerosis. 2019. Available at https://cks.nice.org.uk/topics/multiple-sclerosis/#!backgroundSub (accessed August 2020).
Multiple Sclerosis Trust. Nerve cells (neurons). 2018. Available at https://www.mstrust.org.uk/a-z/nerve-cells-neurons (accessed August 2020).
MS Society. MS in the UK. 2020. Available at https://www.mssociety.org.uk/what-we-do/our-work/our-evidence/ms-in-the-uk (accessed August 2020).
Public Health England. Multiple sclerosis: prevalence, incidence and smoking status - data briefing. 2020. Available at https://www.gov.uk/government/publications/multiple-sclerosis-prevalence-incidence-and-smoking-status/multiple-sclerosis-prevalence-incidence-and-smoking-status-data-briefing (accessed August 2020).
NHS. Overview: multiple sclerosis. 2018. Available at https://www.nhs.uk/conditions/multiple-sclerosis/ (accessed August 2020).
Multiple Sclerosis Trust. Multiple sclerosis information for health and social care professionals. 4th ed. 2011. Available at https://support.mstrust.org.uk/file/ms-info-health-professionals.pdf (accessed August 2020).
Tao C, Simpson Jr S, van der Mei I et al. Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis. J Neurol Neurosurg Psychiatry 2016; 87: 1343-1349.
Dobson R, Giovannoni G. Multiple sclerosis - a review. Eur J Neurol 2019; 26: 27-40.
Multiple Sclerosis Trust. Types of MS. 2020. Available at https://www.mstrust.org.uk/about-ms/what-ms/types-ms (accessed November 2020).
Polman C H, Reingold S C, Banwell B et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
Lewis D, Fiske J, Dougall A. Access to special care dentistry, part 7. Special care dentistry services: seamless care for people in their middle years-part 1. Br Dent J 2008; 205: 305-317.
Tintore M, Vidal-Jordana A, Sastre-Garriga J. Treatment of multiple sclerosis-success from bench to bedside. Nat Rev Neurol 2019; 15: 53-58.
Joint Formulary Committee. British National Formulary. Available online at http://www.medicinescomplete.com (accessed August 2020).
National Institute for Health and Care Excellence. Multiple sclerosis in adults: management. 2014. Available at https://www.nice.org.uk/guidance/cg186 (accessed August 2020).
National Institute for Health and Care Excellence. Cannabis-based medicinal products. 2019. Available at https://www.nice.org.uk/guidance/ng144/chapter/Recommendations#spasticity (accessed August 2020).
Scolding N J, Pasquini M, Reingold S C, Cohen J A. Cell-based therapeutic strategies for multiple sclerosis. Brain 2017; 140: 2776-2796.
Dowse R, McLornan D P. Principles of haemopoietic stem cell transplantation. Medicine 2017; 45: 322-326.
Baker D, Jackson S J, Pryce G. Cannabinoid control of neuroinflammation related to multiple sclerosis. Br J Pharmacol 2007; 152: 649-654.
Zajicek J P, Apostu V I. Role of cannabinoids in multiple sclerosis. CNS Drugs 2011; 25: 187-201.
Navarrete C, García-Martin A, Garrido-Rodríguez M et al. Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis. Neurobiol Dis 2020; 143: 104994.
Eulalia-Troisfontaines E S, Martinez-Perez E-M, Miegimolle-Herrero M, Planells-del-pozo P. Oral health status of a population with multiple sclerosis. Med Oral Patol Oral Cir Bucal 2012; DOI: 10.4317/medoral.17340.
Kovac Z, Uhac I, Bukovi D, Cabov T, Kovacevi D, Grzi R. Oral health status and temporomandibular disorders in multiple sclerosis patients. Coll Antropol 2005; 29: 441-444.
Baird W O, McGrother C, Abrams K R, Dugmore C, Jackson R J. Factors that influence the dental attendance pattern and maintenance of oral health for people with multiple sclerosis. Br Dent J 2007; 202: E4.
Pateman K, Cockburn N, Campbell J, Ford P J. How do Australians living with MS experience oral health and accessing dental care? A focus group study. Community Dent Oral Epidemiol 2017; 45: 84-91.
Teasdale B. Oral health and management of patients with multiple sclerosis. Royal College of Surgeons of England, King's College Hospital, 2018. Diploma in Dental Hygiene and Therapy (unpublished).
Fischer D J, Epstein J B, Klasser G. Multiple sclerosis: an update for oral health care providers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 318-327.
Zhang G-Q, Meng Y. Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider. Eur Rev Med Pharmacol Sci 2015; 19: 4610-4620.
Scully C. Scully's Medical Problems in Dentistry. 7th ed. Edinburgh: Elsevier, 2014.
Department for Constitutional Affairs. Mental Capacity Act 2005: Code of Practice. 2007. Available at https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/497253/Mental-capacity-act-code-of-practice.pdf (accessed August 2020).
Multiple Sclerosis Trust. Speech Problems. 2019. Available at https://www.mstrust.org.uk/a-z/speech-problems (accessed August 2020).
Public Health England and Department of Health. Delivering better oral health: an evidence-based toolkit for prevention. 3rd ed. 2017. Available at https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/605266/Delivering_better_oral_health.pdf (accessed August 2020).
Elad S, Raber-Durlacher J E, Brennan M T et al. Basic oral care for haematology-oncology patients and haematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Support Care Cancer 2015; 23: 223-236.
Kumar N, Brooke A, Burke M, John R, O'Donnell A, Soldani F. The Oral Management of Oncology Patients Requiring Radiotherapy, Chemotherapy and/or Bone Marrow Transplantation. 2018. Available online at https://www.rcseng.ac.uk/dental-faculties/fds/publications-guidelines/clinical-guidelines/ (accessed August 2020).
Health Education England. Mouth Care Matters: Cleaning the mouth of an adult with a neuro-disability. 2019. Available at http://mouthcarematters.hee.nhs.uk/wp-content/uploads/sites/6/2019/09/2-RHN-FS-Cleaning-the-mouth-of-an-adult-with-a-Neuro-Disability.pdf (accessed 03 August 2020).